Occudo Quantitative Strategies’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,518
Closed -$700K 1288
2023
Q3
$700K Buy
+3,518
New +$832K 0.09% 388
2023
Q1
Sell
-1,344
Closed -$276K 1273
2022
Q4
$276K Sell
1,344
-12,480
-90% -$3.16M 0.03% 685
2022
Q3
$3.84M Buy
+13,824
New +$3.52M 0.3% 62
2022
Q2
Sell
-4,783
Closed -$992K 1442
2022
Q1
$992K Sell
4,783
-1,826
-28% -$301K 0.08% 383
2021
Q4
$1.18M Sell
6,609
-2,118
-24% -$418K 0.1% 305
2021
Q3
$1.8M Buy
8,727
+537
+7% +$105K 0.22% 106
2021
Q2
$1.55M Buy
8,190
+5,462
+200% +$894K 0.24% 109
2021
Q1
$355K Buy
+2,728
New +$327K 0.08% 439

Other funds holding SWAV

Occudo Quantitative Strategies's SWAV Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 3,518 shares — an estimated $700K sold.

Occudo Quantitative Strategies first reported a position in SWAV in Q1 2021 and held it in 8 quarters. The position peaked at $3.84M in Q3 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Occudo Quantitative Strategies reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 3,518 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $700K.
  • Occudo Quantitative Strategies first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Occudo Quantitative Strategies's Shockwave Medical, Inc. Common Stock position peaked at $3.84M in Q3 2022.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.